TITLE

GENEFORMATICS/DE NOVO FORM DRUG DISCOVERY COLLABORATION

PUB. DATE
September 2002
SOURCE
Worldwide Biotech;Sep2002, Vol. 14 Issue 9, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Announces that GeneFormatics Inc. and De Novo Pharmaceuticals Ltd. have formed a collaborative drug discovery program to elucidate inhibitors of matrix metalloproteinases.
ACCESSION #
7248242

 

Related Articles

  • 3-D PROTEIN STRUCTURAL INFORMATION ENABLES DRUG DISCOVERY.  // Online Product News;Feb2001, p2 

    Reports on Structural Bioinformatics Inc.'s announcement that De Novo Pharmaceuticals has entered into an agreement to access multiple therapeutic target classes within the SBI SBdBase. Other databases within the SBI ProMax three-dimensional protein structure database series; Proprietary...

  • DE NOVO SIGNS PACT TO ACCESS SBI'S SBDBASE DATABASE.  // Worldwide Databases;Jan2001, Vol. 13 Issue 1, p2 

    Reports on San Diego, California-based Structural Bioinformatics Inc.'s agreement with De Novo Pharmaceuticals to provide the latter with access to the former's SBdBase, a three-dimensional protein structure database; Importance of the database in the drug discovery and design process.

  • UK firms form alliance in synthesis and design. Whitfield, Mark // European Chemical News;4/14/2003, Vol. 78 Issue 2048, p24 

    Reports on the collaboration between British chemical firms Peakdale Molecular and De Novo Pharmaceuticals to exploit their respective skills in chemistry synthesis and molecular design. Expertise of De Novo; Experience of Peakdale in the design, creation and synthesis of novel chemotypes in...

  • GENEFORMATICS/INCYTE RESEARCH PROTEIN SEQUENCE FUNCTIONS.  // Biotech Business;Jun2002, Vol. 15 Issue 6, p3 

    States that GeneFormatics Inc. and Incyte Genomics Inc. have entered into a collaborative research agreement on protein sequence functions.

  • De-Lovely Pharmaceuticals. Davies, Kevin // Bio-IT World;Nov2004, Vol. 3 Issue 11, p44 

    Focuses on the screening strategy of De Novo Pharmaceuticals in drug discovery. Capabilities of Skelgen, the company's design technology platform; Way of assessing the chemical fragment library; Partnership of De Novo Pharmaceuticals with Hoffman-La Roche, Eli Lilly and with Peakdale Molecular Ltd.

  • Improving industry-government cooperative R&D. Ham, Rosie Marie; Mowery, David C. // Issues in Science & Technology;Summer95, Vol. 11 Issue 4, p67 

    Discusses the February 1995 report of Energy Secretary's Task Force on Alternatives Futures for the Department of Energy (DOE) National Laboratories. Role of Cooperative Research and Development Agreements (CRADA) after the implementation of the report.

  • Can US still devise a better widget? Belsie, Laurent // Christian Science Monitor;4/10/96, Vol. 88 Issue 94, p4 

    Reports that the United States have become complacent about long term research. Reasons for this; Effects proposed budget cuts could have on the 1996 Research and development fundings; Comments from Eric Bloch, a fellow at the Council on Competitiveness, a private group of the United States'...

  • Agreement reached. Maurer, Michael // Crain's Detroit Business;9/12/94, Vol. 10 Issue 37, p2 

    Reports on the research-and-development agreement between United States Army Tank-Automotive Research, Development and Engineering Center and the Greater Detroit Free-Net. Development of Free-Net as a virtual business.

  • India's emergence as a global R&D platform: The new challenges and opportunities. Mashelkar, R.A. // Chemical Business;1995/96 Annual, Vol. 9 Issue 5, p83 

    Focuses on research and development in India. International trends; Alliances with other countries; Benefits to India; Issues affecting progress.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics